Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF<sup>V600E</sup> Mutated Anaplastic Thyroid Carcinoma

Author:

Hamidi Sarah1,Iyer Priyanka2,Dadu Ramona2,Gule-Monroe Maria3,Maniakas Anastasios4,Zafereo Mark E.5,Wang Jennifer R.6,Busaidy Naifa7,Cabanillas Maria1

Affiliation:

1. The University of Texas MD Anderson Cancer Center, 4002, Endocrine Neoplasia and Hormonal Disorders, Houston, Texas, United States, ;

2. The University of Texas MD Anderson Cancer Center, 4002, Department of Endocrine Neoplasia and Hormonal Disorders, Houston, Texas, United States, ;

3. University of Texas MD Anderson Cancer Center, 4002, Department of Diagnostic Radiology, Division of Diagnostic Imaging, 1515 Holcombe Blvc, Houston, Texas, United States, 77030, ;

4. University of Texas MD Anderson Cancer Center Division of Surgery, 461926, Head and Neck Surgery, 1515 Holcombe Blvd., Houston, Texas, United States, 77030, ;

5. University of Texas MD Anderson Cancer Center, 4002, Head and Neck Surgery, 1515 Holcombe Boulevard Unit 1445, Department of Head & Neck Surgery, Houston, Texas, United States, 77030, ;

6. University of Texas MD Anderson Cancer Center, 4002, Head and Neck Surgery, 1515 Holcombe Blvd, Unit 1445, Houston, Texas, United States, 77030-4000, ;

7. The University of Texas MD Anderson Cancer Center, 4002, Endocrine Neoplasia & Hormonal Disorders, Houston, Texas, United States, ;

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3